Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVOTF) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Evotec SE (EVOTF) over the last 9 years, with Q3 2025 value amounting to $207.7 million.

  • Evotec SE's Shares Outstanding (Weighted Average) rose 664.39% to $207.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.7 million, marking a year-over-year increase of 664.39%. This contributed to the annual value of $189.5 million for FY2024, which is 47.03% down from last year.
  • According to the latest figures from Q3 2025, Evotec SE's Shares Outstanding (Weighted Average) is $207.7 million, which was up 664.39% from $189.5 million recorded in Q4 2024.
  • In the past 5 years, Evotec SE's Shares Outstanding (Weighted Average) ranged from a high of $207.7 million in Q3 2025 and a low of $1768.9 during Q3 2021
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $190.4 million (2023), whereas its average is $164.4 million.
  • Data for Evotec SE's Shares Outstanding (Weighted Average) shows a peak YoY increase of 1007178768.4% (in 2022) and a maximum YoY decrease of 531.2% (in 2022) over the last 5 years.
  • Over the past 5 years, Evotec SE's Shares Outstanding (Weighted Average) (Quarter) stood at $190.4 million in 2021, then decreased by 5.31% to $180.3 million in 2022, then grew by 5.6% to $190.4 million in 2023, then dropped by 0.47% to $189.5 million in 2024, then grew by 9.63% to $207.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $207.7 million in Q3 2025, compared to $189.5 million in Q4 2024 and $194.8 million in Q3 2024.